• ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Average Recommendation of "Buy" from Analysts

    Source: Buzz FX / 28 Nov 2024 03:36:11   America/New_York


    ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Average Recommendation of "Buy" from Analysts Written by MarketBeat November 28, 2024 Share Link copied to clipboard. ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Get Free Report ) has been give
    Read more...
Share on,